Three of thirty-six monoclonal antibodies were found to cause irreversible inactivation of tpe 1 poliovirus at 39°C but not at 37°C. Neutralization at 37°C depended on aggregation and was reversible by acid-induced deaggregation; at 39°C, the virions (N antigenic, 160S) were disrupted to empty capsids (H antigenic, 100S), and neutralization was irreversible. The rate of antibody-dependent conversion of N to H antigen increased steeply between 37 and 39°C.
steeply between 37 and 39°C.
The neutralization of picornaviruses in suspension involves different mechanisms (15) . The virions may undergo aggregation, i.e., cross-linking without intrinsic damage (1, 3, 19, 20) ; they may be covered by enough antibody to impede their adsorption to host cell receptors (1, 6) ; their uncoating may be prevented even after adsorption (9) ; and finally, the virions may be killed outright by disruption to empty capsids, with release of RNA (disruptive neutralization) (4, 7, 13) . Neutralization by aggregation can be reversed by a brief treatment at low pH, owing to dissociation of the virus-antibody complexes (12) . In contrast, disruptive neutralization is irreversible (4) .
Some monoclonal antibodies (MAbs), including 35-1f4, are able to neutralize poliovirus by more than one mechanism, depending on the molar ratio of MAb to virus and on the composition of the medium. The propensity of MAb 35-1f4 for aggregation is related to its capacity for bigamous binding and to its unsuitability for monogamous bivalency (21) . At normal ionic strength at 37°C, MAb 35-1f4 neutralizes type 1 poliovirus exclusively by aggregation, and the process is fully reversible by acid treatment (3, 4, 19) , but at low ionic strength, a disruptive and irreversible mechanism prevails (4, 7) . In this report, we show that disruptive neutralization of poliovirus by 35-1f4 and a few other MAbs can be induced even at normal ionic strength, by simply raising temperature from 37 to 39°C. Thus, febrile temperatures activate a virus-killing mechanism that does not exist at normal body temperature.
MATERIALS AND METHODS
Virus. Purified type 1 (Mahoney) poliovirus was used throughout. Virus purification and labeling with tritiated valine, leucine, and uridine were as described previously (10) . The purified virus was 100% bound by N-specific MAbs in immunoprecipitation tests (22) , whereas no measurable binding occurred with H-specific antibodies; it can therefore be referred to as pure N antigen.
Plaque titration was performed as described previously (21) except that incubation after addition of the inoculum was at 37°C instead of 4°C.
MAbs (Table 2 ). When the treatment had been at 37°C, the original titer was regained upon acid treatment, but when it had been at 39'C, the acid treatment caused only a slight recovery (from 7.0 to 7.4). The reaction mixtures were submitted to centrifugation in sucrose density gradients to determine the RNA profiles (Fig. 1) . The bulk of the RNA in the control without antibody was associated with 160S virions (Fig. 1A) . As expected, the virus was aggregated after neutralization at 37'C (Fig. 1B) , and most of the RNA radioactivity reverted to the 160 S position after acid treatment (Fig. 1C) . In contrast, when neutralization had been at 39'C, the RNA sedimented near the top of the gradient, . After 2 h at either 37 or 39°C, the reaction was stopped by cooling on ice. A portion of each mixture was acidified to pH 2.0 with citric acid and was allowed to stand for 30 min at room temperature. A 0.020-ml sample of each was layered onto a sucrose gradient for centrifugation as described for Fig. 1 . Another sample was diluted 1:100 in PBS to restore pH 7.2 and immediately titrated by plaque count. showing that it had been released from the virions (Fig. 1D) . The results emphasize the temperature dependence of virion disruption: the RNA was released at 39°C but not at 37°C, even though the antibody, the medium, and the degree of neutralization were the same.
The sedimentation of the residual particles was studied by using [3H] valine-labeled virus, and the possible association of MAb 35-1f4 with those particles was examined by using 14C-labeled antibody (Fig. 2) . As expected, the viral protein was associated with aggregates after antibody treatment at 37'C ( Fig. 2A) . After treatment at 39'C, the protein formed a single peak of empty capsids; these did not retain antibody, meaning that they had lost their N antigenicity (Fig. 2B ). In the same experiment, a virus sample was treated with antibody at low ionic strength at 37°C, to allow direct comparison with the empty capsids formed at 39'C (Fig. 2C) . Inspection of Fig. 2B and C shows that the empty capsids generated under the two sets of conditions had different sedimentation velocities; the sedimentation coefficient of the The antigenicity of the 100S empty capsids was examined by immunoprecipitation (7, 22) . As shown in Table 3 , they were 100% H antigenic. In fact, the whole mixture was 96% H antigenic (as opposed to only 22% in the control without antibody), meaning that the extent of antibody-mediated virus disruption could also be measured as a percentage of conversion of N to H antigen, without fractionation of the mixture.
We studied the temperature dependence of the antigenic conversion between 37 and 42°C (Fig. 3) . In these experiments, the virus concentration was kept constant, and the antibody was added in molar ratios of 1, 10, and 100 molecules per virion. The amount of antibody-mediated conversion surged up between 37 and 38°C, with a further increase at 39°C. Above 39°C, only the antibody-independent conversion increased; spontaneous conversion also accounted for most of the antigenic conversion that took place after 2 h.
The rate of antibody-dependent conversion increased with the concentration of the antibody, albeit less than proportionally. At the lowest (1:1) molar ratio, it amounted to roughly 20%, meaning that each antibody molecule converted an average of only 0.2 virion. This yield is approximately 10 times lower than was observed at low ionic strength at 37°C (7) .
A survey of 36 MAbs from three laboratories yielded a [3Hlleucine-labeled poliovirus (0. to fever level, with most of the increase occurring between 37 and 380C. We do not know of any similar report.
Only 3 of 36 MAbs were found that caused irreversible neutralization at 39°C but not at 37°C, suggesting that these features belonged to only a minority of antibodies. This also appears to hold true for polyclonal sera: we observed some irreversible poliovirus neutralization, but its extent was not much greater at 39°C than at 370C (data to be published elsewhere). Even so, the very existence of these antibodies may offer an alternative explanation for the protective effects of fever that have often been noted in both viral and bacterial disease (2, 8) . There is evidence of protection by elevated body temperature in experimental poliomyelitis. Early investigators showed that hyperpyrexia treatment of intracerebrally infected monkeys prevented the development of poliomyelitis completely or affected the disease in such a way that the symptoms were only slight and transitory (23) . In similar experiments with mice, passively induced hyperthermia prevented or delayed the lethal effects of poliovirus infection (11) .
Protective effects of fever in virus diseases have usually been ascribed to enhanced phagocytosis or to lowered microbial multiplication (2, 8) . Fever activation of antibodies should now be added to the list.
